HIGHLIGHTS
- who: In addition et al. from the Laboratory Animals the Association for Assessment and Animal Policy and Welfare Committee of the Yonsei UniversityMedicine, Seoul, Republic of Korea have published the Article: Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model, in the Journal: (JOURNAL) of 30/09/2021
- what: This study showed hepatoprotective effects of L- and H-UDCA in conjunction with RSV/EZE. The authors first found that H-UDCA/RSV/EZE treatment decreased serum ALT levels and mRNA levels of fibrosis-related factors compared to L . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.